title: [Genomics and personalized medicine].
abstract: Personalized medicine has a substantial potential to transform the way diseases will be predicted, prevented and treated. The field will greatly benefit from novel DNA sequencing technologies, in particular commoditization of individual whole genome sequencing. This evolution cannot be stopped, and the medical and scientific community, as well as the society at large, have the responsibility to anticipate the expected benefits from this revolution, but also the potential risks associated with it. Massive investments will be needed for the potential of personalized medicine to be realized, and for the field to come to maturity. In particular, a paradigm change in the way clinical research is done is needed. Switzerland and its Western part pro-actively anticipate these changes.
authors.affiliation: Département des Laboratoires, CHUV Lausanne.
authors.forename: Vincent
authors.initials: V
authors.lastname: Mooser
mesh_terms: D055808:Drug Discovery; D005544:Forecasting; D036281:Genetic Research; D005820:Genetic Testing / Q000639:trends; D023281:Genomics / Q000639:trends*; D006801:Humans; D057285:Precision Medicine / Q000639:trends*; D017422:Sequence Analysis, DNA; D013557:Switzerland
keywords: Genetik; Genomik; Medikamente; drug discovery; genetics; genomics; génomique; génétique; médecine personnalisée; médicaments; personalisierte Medizin; personalized medicine